Cargando…

The Federal ’Right To Try’ Act: An Answer to New Treatments During Terminal Illness?

The newly proposed Federal "Right to Try" Act permits terminally ill patients to try experimental therapies that have completed phase I testing but have not been approved by the FDA. However, there are concerning provisions of the legislature regarding liability and costs.

Detalles Bibliográficos
Autor principal: Viale, Pamela Hallquist
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040874/
https://www.ncbi.nlm.nih.gov/pubmed/30018839